Another phosphate binder (Sevelamer)

DRUG2 trials

Sponsors

Tanabe Pharma Corporation

Conditions

Chronic Kidney DiseaseDialysisHyperphosphatemia

Phase 3

A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia

CompletedNCT00416520

Tanabe Pharma CorporationChronic Kidney Disease, Hyperphosphatemia

Start: 2007-06-30End: 2009-11-30Updated: 2026-01-08

A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

CompletedNCT00542815

Tanabe Pharma CorporationChronic Kidney Disease, Dialysis, Hyperphosphatemia

Start: 2007-11-30End: 2010-08-31Updated: 2026-01-07